Skip to main content

3 Result(s)

within Naohiro Miyashita Remove this filter Oncology Remove this filter

and

  1. No Access

    Article

    Loss of nivolumab binding to T cell PD-1 predicts relapse of Hodgkin lymphoma

    Nivolumab is effective in the treatment of classical Hodgkin lymphoma that relapsed after allogeneic hematopoietic stem cell transplantation (SCT) with the risk of graft-versus-host disease; however, the optim...

    Reiki Ogasawara, Daigo Hashimoto, Junichi Sugita… in International Journal of Hematology (2020)

  2. No Access

    Article

    A novel heterozygous ITGB3 p.T720del inducing spontaneous activation of integrin αIIbβ3 in autosomal dominant macrothrombocytopenia with aggregation dysfunction

    We identified a novel heterozygous ITGB3 p.T720del mutation in a pedigree with macrothrombocytopenia exhibiting aggregation dysfunction. Platelet aggregation induced by ADP and collagen was significantly reduced,...

    Naohiro Miyashita, Masahiro Onozawa, Koji Hayasaka, Takahiro Yamada… in Annals of Hematology (2018)

  3. No Access

    Article

    HBV reactivation in malignant lymphoma patients treated with rituximab and bendamustine

    Yutaka Tsutsumi, Reiki Ogasawara, Naohiro Miyashita… in International Journal of Hematology (2012)